Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

CirclSeq


Summary

Automatable and reliable preparation of a DNA library in a one-vial reaction for unbiased quantification of mRNA


Technology Benefits

One-vial reaction
Enables the unbiased amplification-free gene expression analysis from cells or biological samples
Reflects the real status of the cell
Pooling of samples is possible after the first reaction step
* The technique is
* automatable
* reliable
* time-saving
* cost-saving and
* amenable to high throughput


Technology Application

This method offers the possibility of an automatable, time- and cost-saving high throughput sequencing technique of mRNA or other nucleic acid molecules without the need for prior amplification.


Detailed Technology Description

The blocking of all 3' ends by the untemplated incorporation of di-desoxy-TTP (ddTTP) by terminal desoxynucleotidyl transferase hinders non-elongated primers from circularization and thus from later sequencing. Additional purification steps to remove the primers are not necessary anymore. cDNA digestion at dUTP sites still gives rise to 3'OH ends that can be circularized and analyzed by deep sequencing subsequently.
Thus, this novel method allows much higher throughput and maximizes the overall yield and the fraction of sequencing reads corresponding to real mRNA templates.


Type of Cooperation

Licensing


Application Date

30/10/2015 00:00:00


Application No.

US201514929079 20151030


Classes

- international:
C12N15/10; C12Q1/68
- cooperative:
default
C12N15/1065; C12Q1/6806

C-sets
C12Q1/6806, C12Q2521/107, C12Q2521/301, C12Q2525/119, C12Q2525/307, C12Q2527/137


Others

Patent application


ID No.

4031


Country/Region

Germany

For more information, please click Here
Business of IP Asia Forum
Desktop View